NIH-funded research NIH-funded research

Exploring how certain antimicrobial peptides can fight antibiotic-resistant bacteria.

Official title: Investigating beta-hairpin antimicrobial peptide membrane activity and toxicity.

Funded at University of Missouri Kansas City · NIH-10785418 · Data updated 2026-11-12

This study is exploring special proteins that can fight off tough bacteria that don't respond to regular antibiotics, with the hope of finding new and better treatments for infections.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Missouri Kansas City
NIH-funded
Lab location1 site (Kansas City, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$158,800
NIH project number1K22AI179937-01
Project IDNIH-10785418 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals suffering from bacterial infections that are resistant to current antibiotic treatments.

Less likely to help

Patients with non-bacterial infections or those who do not have antibiotic-resistant infections may not benefit from this research.

What this research studies

This research focuses on understanding the structure and function of β-hairpin antimicrobial peptides, which are promising candidates for combating antibiotic-resistant pathogens. The project aims to develop new strategies for antibiotic discovery by investigating how these peptides can penetrate bacterial membranes and disrupt their function. By utilizing a novel synthetic peptide screening technique, the research will analyze thousands of synthetic β-AMPs to determine their antibacterial potency and toxicity to mammalian cells. This could lead to the development of more effective treatments for bacterial infections.

Why it matters

Potential benefit: If successful, this research could lead to the development of new antibiotics that are effective against resistant bacterial infections.

How similar studies have gone: Other research has shown promise in using antimicrobial peptides to combat bacterial resistance, indicating that this approach has potential for success.

Where this research is happening

  • University of Missouri Kansas City
    Kansas City, United States
    Active

Researchers

  • Principal investigator: Randall, Justin Roy — University of Missouri Kansas City
  • Study coordinator: Randall, Justin Roy

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.